RENE
Get informed when a big investor buys or sells
+ FollowOvervalued by 103.7% based on the discounted cash flow analysis.
| Market cap | $36.14 Million |
|---|---|
| Enterprise Value | $36.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | -0.01 |
| Outstanding Shares | 3,076,094 |
| P/E Ratio | 105.92 |
|---|---|
| PEG | 29.46 |
| Price to Sales | - |
| Price to Book Ratio | 2.94 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -28.94 |
| Enterprise Value to Net Income | 75 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 60.69%▼ 30.89% |
|---|---|
| Total Invested | $41.65M▼ 47.09% |
| Investors Holding | 4▼ 13.00% |
No data
Cartesian Growth Corporation II currently lacks significant ongoing business activities. Established in New York, New York, in 2021, its core objective is to execute a business combination, which may take various forms such as a merger, ...